Funding available for research on ethical, legal, and social impacts of human genetics and genomics, with focus on new technologies and stakeholder involvement.
NHGRI plans to fund research on the ethical, legal, and social issues arising from advances in genomics, encouraging multidisciplinary approaches to address their impact on individuals and society.
NCI seeks bioengineering innovation to enhance solutions for cancer research and care in exploratory/developmental grants.
Encouraging grant applications for bioengineering innovations in cancer research and healthcare to enhance quality, speed, and accessibility.
NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.
NIH's R21 grant funds high-risk, early-stage research with potential for breakthroughs in biomedical, behavioral, or clinical fields, excluding clinical trials.